Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Tariq Musa reports the disposition of common stock and restricted stock units in Guardant Health, Inc.

Summary

  • On June 15, 2024, Tariq Musa, a director of Guardant Health, Inc., reported a transaction involving the disposition of 250 shares of common stock at a price of $0.
  • This transaction was related to the vesting of restricted stock units.
  • Following the reported transaction, Musa directly owns 3,747 shares of common stock and 8,245 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings and transactions of company directors.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.
  • It has a minimal impact on other stakeholders.

Key Dates

DateDescription
03/06/2023Date the restricted stock units were granted.
03/15/2023First vesting date of the restricted stock units.
06/15/2024Date of the reported stock transaction (disposition of shares due to vesting of restricted stock units).
06/17/2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.